News & Events :: Alzamend Neuro, Inc. (ALZN)

NASDAQ: ALZN

Recent NewsView All News

Mar 18, 2025 8:00am EDT

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital

Mar 11, 2025 8:00am EDT

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital

Upcoming Events View All Events

April 25, 2025 12:00 pm EDT

2025 Annual Meeting of Stockholders

View All Events

Latest Presentation View All Presentations

Corporate Presentation

View All Presentations

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings